title: Exploring marine resources for bioactive compounds.
abstract: Biodiversity in the seas is only partly explored, although marine organisms are excellent sources for many industrial products. Through close co-operation between industrial and academic partners, it is possible to successfully collect, isolate and classify marine organisms, such as bacteria, fungi, micro- and macroalgae, cyanobacteria, and marine invertebrates from the oceans and seas globally. Extracts and purified compounds of these organisms can be studied for several therapeutically and industrially significant biological activities, including anticancer, anti-inflammatory, antiviral, antibacterial, and anticoagulant activities by applying a wide variety of screening tools, as well as for ion channel/receptor modulation and plant growth regulation. Chromatographic isolation of bioactive compounds will be followed by structural determination. Sustainable cultivation methods for promising organisms and biotechnological processes for selected compounds can be developed, as well as biosensors for monitoring the target compounds. The (semi)synthetic modification of marine-based bioactive compounds produces their new derivatives, structural analogs and mimetics that could serve as hit or lead compounds and be used to expand compound libraries based on marine natural products. The research innovations can be targeted for industrial product development in order to improve the growth and productivity of marine biotechnology. Marine research aims at a better understanding of environmentally conscious sourcing of marine biotechnology products and increased public awareness of marine biodiversity. Marine research is expected to offer novel marine-based lead compounds for industries and strengthen their product portfolios related to pharmaceutical, nutraceutical, cosmetic, agrochemical, food processing, material and biosensor applications.
authors.affiliation: Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Finland.
authors.forename: Paula
authors.initials: P
authors.lastname: Kiuru
authors.affiliation: Department of Pharmacy, University of Naples Federico II, Naples, Italy.
authors.forename: M Valeria
authors.initials: MV
authors.lastname: DʼAuria
authors.affiliation: Laboratoire d'Innovation Thérapeutique UMR CNRS 7200, Faculté de Pharmacie, Université de Strasbourg, Illkirch, France.
authors.forename: Christian D
authors.initials: CD
authors.lastname: Muller
authors.affiliation: Centre for Drug Research, Faculty of Pharmacy, University of Helsinki, Finland.
authors.forename: Päivi
authors.initials: P
authors.lastname: Tammela
authors.affiliation: Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Finland.
authors.forename: Heikki
authors.initials: H
authors.lastname: Vuorela
authors.affiliation: Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Finland.
authors.forename: Jari
authors.initials: J
authors.lastname: Yli-Kauhaluoma
mesh_terms: D000818:Animals; D059001:Aquatic Organisms / Q000737:chemistry*; D001419:Bacteria / Q000737:chemistry*; D044822:Biodiversity; D001688:Biological Products / Q000494:pharmacology*; D000458:Cyanobacteria / Q000737:chemistry; D005399:Fishes; D005658:Fungi / Q000737:chemistry*; D006801:Humans; D007448:Invertebrates / Q000737:chemistry*; D058086:Microalgae / Q000737:chemistry*; D012624:Seaweed / Q000737:chemistry*
chemical_list: D001688:Biological Products